Case Study: Legend Biotech scales CAR-T manufacturing with Binocs from Bluecrux

Legend Biotech scales CAR-T manufacturing to 16 patients a day with Bluecrux

Legend Biotech, a cell therapy company, faced a significant challenge in scaling its CAR-T manufacturing operations. With demand far exceeding supply, their reliance on manual scheduling via whiteboards and spreadsheets became unsustainable, risking missed patient treatment slots and creating constant rescheduling pressure. To overcome this, they partnered with Bluecrux and implemented its AI-powered planning and scheduling platform, Binocs.

The solution from Bluecrux provided a single, trusted schedule that automated planning based on critical constraints. This enabled Legend Biotech to achieve near-100% utilization of its manufacturing capacity, treat over 8,000 patients, and confidently ramp up to a network capacity of 10,000 patients per year. The implementation of Binocs was critical for Legend Biotech to scale its complex operations effectively while maintaining its commitment to patient access.

Legend Biotech